The maximum chemiluminescence intensity predicts severe neutropenia in gemcitabine-treated patients with pancreatic or biliary tract cancer

PURPOSE: To assess the predictive ability of the maximum chemiluminescence intensity (CI(max)) for severe neutropenia (SN) during neoadjuvant chemo(radio)therapy [NAC(RT)] in patients with advanced pancreatic or biliary tract cancer. METHODS: Clinicopathological variables and blood test data before...

Descripción completa

Detalles Bibliográficos
Autores principales: Goto, Koki, Matsuyama, Ryusei, Suwa, Yusuke, Arisaka, Sayaka, Kadokura, Toshiaki, Sato, Mari, Mori, Ryutaro, Kumamoto, Takafumi, Taguri, Masataka, Endo, Itaru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267671/
https://www.ncbi.nlm.nih.gov/pubmed/30218151
http://dx.doi.org/10.1007/s00280-018-3685-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267671/
https://www.ncbi.nlm.nih.gov/pubmed/30218151
http://dx.doi.org/10.1007/s00280-018-3685-6

Ejemplares similares